Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1635 1674 1682
This examiner grants 27% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18271926 | COMBINATION THERAPEUTICS FOR TREATMENT OF PROLIFERATIVE DISORDERS | Non-Final OA | GEORGIA TECH RESEARCH CORPORATION |
| 19413886 | PHARMACEUTICAL COMPOSITIONS FOR DELIVERY TO THE EYE | Non-Final OA | Astellas US LLC |
| 18063824 | CELLULAR UPTAKE OF FUNCTIONALIZED DNA NANOSTRUCTURES | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 16955508 | Bivalent Nucleic Acid Ligands and Uses Therefor | Final Rejection | Carnegie Mellon University |
| 18024182 | COMPOSITIONS AND METHODS FOR TREATING THERAPY RESISTANT CANCER | Non-Final OA | The General Hospital Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy